Exercise During the Allogeneic Stem Cell Transplantation
Phase 3
- Conditions
- FatigueAllogeneic Stem Cell Transplantation
- Registration Number
- NCT00883714
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The study will evaluate the effects of a structured endurance exercise program on the physical performance, the mood and the complications of patients with hematological malignancies undergoing a high-dose chemotherapy followed by an allogeneic peripheral blood stem cell transplantation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Neoplastic malignancy
- Allogeneic peripheral stem cell transplantation
- Proficiency in German
Exclusion Criteria
- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
- Pathological stress-ECG at admission
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method VO2max At recruitment and after 4 weeks
- Secondary Outcome Measures
Name Time Method Complications 4 weeks Mood At recruitment and after 4 weeks Requirement for blood and platelets transfusions 4 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link endurance exercise to reduced complications in allogeneic stem cell transplantation?
How does supervised exercise compare to standard-of-care in managing fatigue post-allogeneic stem cell transplant?
Are there specific biomarkers that predict patient response to structured exercise during high-dose chemotherapy?
What adverse events are associated with exercise interventions in hematological malignancy patients undergoing allogeneic stem cell transplantation?
What combination therapies or drugs synergize with exercise to improve physical performance in allogeneic stem cell transplant recipients?
Trial Locations
- Locations (1)
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
🇩🇪Berlin, Germany
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30🇩🇪Berlin, GermanyFernando Dimeo, MDPrincipal Investigator